Creating Value in other domains

Creating value with Proveblue® API

The molecule is available under licence to pharmaceutical players worldwide which will use the patented Proveblue® active pharmaceutical ingredient to :

  • Explore intrinsic properties of Methylene Blue in health applications, e.g. in life-threatening Malaria,
  • Renew marketing authorisations or approvals of medical devices or drugs containing Methylene Blue,
  • Develop new drugs or devices made with Proveblue®.

Crossing the patent, the compliance to most stringent requirements and the ability to supply GMP material at manufacturing scale will provide increased protection, create value at partners’ and offer a straight forward access to market.

Licensing deals are sought for, preferably exclusive by therapeutic field and territory, in which Provepharm will provide active support in scientific matters, pharmaceutical development and regulatory affairs.